Circulating miR-19b and miR181b are potential biomarkers for diabetic cardiomyopathy
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
11
item.page.accessRights
item.page.other
item.page.references
Abstract
Diabetic cardiomyopathy is characterized by metabolic changes in the myocardium that promote a slow and silent dysfunction of muscle fibers, leading to myocardium remodelling and heart failure, indepe...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Copier CU, León L, Fernández M, Contador D, Calligaris SD. Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy. Sci Rep. 2017 Oct 18;7(1):13514.
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026